Insider trading on April 17, 2025
No open-market insider purchases were reported with this date.
Insiders sold $194 across 1 open-market sale. Selling routinely outweighs buying, because most executive pay is delivered in stock.
Companies bought
0
0 insiders
CEO buys
0
chief executives
Open-market sales
Pre-arranged 10b5-1 trades are marked.
Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.| Date | Ticker | Company | Insider | Role | Type | Shares | Price | Value | Δ Own | Filing |
|---|
| Apr 17, 2025 | PYXS | Pyxis Oncology, Inc. | Humphrey Rachel | Director | SSELL◷ | 200 | $0.97 | $194 | -0.2% | ↗Open the original filing on SEC.gov |